PAGNINI, ILARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.385
EU - Europa 3.099
AS - Asia 2.149
SA - Sud America 295
Continente sconosciuto - Info sul continente non disponibili 114
AF - Africa 62
OC - Oceania 40
Totale 11.144
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.303
RU - Federazione Russa 1.080
IT - Italia 674
SG - Singapore 599
CN - Cina 504
PL - Polonia 408
HK - Hong Kong 332
IE - Irlanda 272
BR - Brasile 240
SE - Svezia 226
VN - Vietnam 221
KR - Corea 172
IN - India 92
FI - Finlandia 86
FR - Francia 86
GB - Regno Unito 79
DE - Germania 71
CA - Canada 50
JO - Giordania 48
AU - Australia 40
BD - Bangladesh 38
JP - Giappone 27
ID - Indonesia 24
AR - Argentina 23
UA - Ucraina 21
AT - Austria 20
TR - Turchia 20
ES - Italia 19
CH - Svizzera 17
IQ - Iraq 16
CI - Costa d'Avorio 15
NL - Olanda 14
ZA - Sudafrica 14
MX - Messico 13
BE - Belgio 9
EC - Ecuador 8
AZ - Azerbaigian 7
MA - Marocco 7
NG - Nigeria 7
PY - Paraguay 7
PK - Pakistan 6
SA - Arabia Saudita 6
UZ - Uzbekistan 6
CL - Cile 5
SC - Seychelles 5
VE - Venezuela 5
EG - Egitto 4
IL - Israele 4
KZ - Kazakistan 4
AE - Emirati Arabi Uniti 3
BH - Bahrain 3
BO - Bolivia 3
BS - Bahamas 3
CO - Colombia 3
CZ - Repubblica Ceca 3
IR - Iran 3
JM - Giamaica 3
KE - Kenya 3
TN - Tunisia 3
BG - Bulgaria 2
DZ - Algeria 2
HR - Croazia 2
LB - Libano 2
LT - Lituania 2
LV - Lettonia 2
MY - Malesia 2
PA - Panama 2
PH - Filippine 2
PR - Porto Rico 2
SV - El Salvador 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
AL - Albania 1
BZ - Belize 1
CG - Congo 1
CR - Costa Rica 1
CY - Cipro 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
GI - Gibilterra 1
GP - Guadalupe 1
HU - Ungheria 1
LA - Repubblica Popolare Democratica del Laos 1
MU - Mauritius 1
NI - Nicaragua 1
NP - Nepal 1
OM - Oman 1
PT - Portogallo 1
RS - Serbia 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 11.031
Salva come PNG Salva come JPEG
Città #
Santa Clara 1.098
Ashburn 637
Fairfield 438
Singapore 429
Warsaw 406
Hong Kong 278
Dublin 266
Chandler 246
Dallas 207
Woodbridge 188
Cambridge 180
Seoul 171
Seattle 170
Beijing 162
Houston 162
Wilmington 151
Milan 149
San Jose 123
Lawrence 101
The Dalles 96
Altamura 95
Council Bluffs 93
Los Angeles 91
Ann Arbor 83
Princeton 79
Ho Chi Minh City 73
Hefei 66
Buffalo 60
Lauterbourg 60
Medford 52
Hanoi 49
Moscow 44
London 41
New York 40
Rome 40
Florence 39
Mumbai 39
Boston 37
Munich 37
Melbourne 34
Shanghai 33
San Diego 32
Clifton 25
Tokyo 25
Helsinki 24
Pune 24
Boardman 21
São Paulo 19
Vienna 19
Jacksonville 18
Kent 18
Jakarta 17
Naples 17
Figino 16
Abidjan 15
Bern 15
Turku 15
Chennai 14
Redondo Beach 14
Toronto 14
Chicago 13
Norwalk 13
Da Nang 12
Falls Church 12
Orem 12
Phoenix 12
Turin 12
Miano 11
Palermo 11
Paris 11
Bologna 10
Hillsboro 10
San Francisco 10
Barcelona 9
Johannesburg 9
Ankara 8
Brooklyn 8
Brussels 8
Dong Ket 8
Genoa 8
Izmir 8
Bari 7
Erbil 7
Guangzhou 7
Philadelphia 7
A Coruña 6
Abuja 6
Columbus 6
Frankfurt am Main 6
Montreal 6
Rio de Janeiro 6
Tashkent 6
Thái Bình 6
Trieste 6
Venice 6
Verona 6
Yubileyny 6
Amsterdam 5
Atlanta 5
Baku 5
Totale 7.535
Salva come PNG Salva come JPEG
Nome #
Alteration of Fecal Microbiota Profiles in Juvenile Idiopathic Arthritis. Associations with HLA-B27 Allele and Disease Status. 306
biologic therapy in children with enthesitis-related arthritis the fist year after disease onset 294
The intestinal microbiota in enthesitis-related arthitis 277
Anti-adalimumab antibodies in a cohort of patients with juvenile idiopathic arthritis: incidence and clinical correlations 245
A peptide-based anti-Adalimumab antibody assay to monitor immune response to biologics treatment in juvenile idiopathic arthritis and childhood chronic non-infectious uveitis 244
Superior efficacy of Adalimumab in treating childhood refractory chronic uveitis when used as first biologic modifier drug: Adalimumab as starting anti-TNF-alpha therapy in childhood chronic uveitis. 237
Early anti IL-1 treatment replaces steroids in refractory Kawasaki disease: clinical experience from two case reports 235
Immunosuppressive Activity of Abatacept on Circulating T Helper Lymphocytes from Juvenile Idiopathic Arthritis Patients 231
Serum amyloid A circulating levels and disease activity in patients with juvenile idiopathic arthritis. 226
Identification of autoantibodies against inner ear antigens in a cohort of children with idiopathic sensorineural hearing loss. 215
Congenital heart block and immune mediated sensorineural hearing loss: possible cross reactivity of immune response 210
Oral clonidine provocative test in the diagnosis of growth hormone deficiency in childhood: should we make the timing uniform? 208
Bone status of children born from mothers with autoimmune diseases treated during pregnancy with prednisone and/or low molecular weight heparin. 207
Difficult-To-Treat Juvenile Idiopathic Arthritis: Current and Future Options 191
Surface plasmon resonance-based methodology for anti-adalimumab antibody identification and kinetic characterization 190
Clinical and transcriptional response to the long-acting interleukin-1 blocker canakinumab in Blau syndrome-related uveitis. 187
Fast recovery of cardiac function in PIMS-TS patients early using intravenous anti-IL-1 treatment 171
The off-label use of anakinra in pediatric systemic autoinflammatory diseases 170
AB1025 Chronic Recurrent Multifocal Osteomyelitis (CRMO): The Importance of an Accurate Differential Diagnosis 167
The Development of Extra-Articular Manifestations in Children With Enthesitis-Related Arthritis: Natural Course or Different Disease Entity? 165
Clinical features and outcome of Cogan syndrome. 164
Ocular involvement in monogenic autoinflammatory disease: A systematic literature review 162
Thrombotic Events in MIS-C Patients: A Single Case Report and Literature Review 160
Successful treatment with canakinumab of a paediatric patient with resistant Behçet's disease 160
Clinical and Therapeutic Features of 312 Patients with Macrophage Activation Syndrome Enrolled in a Multinational Survey 158
Acute hemorrhagic edema of infancy: 20‐year experience from an Italian tertiary referral center 156
Switching from Reference to Biosimilars Does Not Reduce Efficacy and Safety in Juvenile Idiopathic Arthritis 156
STAT3-confusion-of-function: Beyond the loss and gain dualism 155
Distal extremity pain as a presenting feature of Fabry's disease. 155
Sequential MR angiography in childhood primary angiitis of the CNS. 155
Glucocorticoids in the management of systemic juvenile idiopathic arthritis. 155
OBSIDIAn - real world evidence of Originator to BioSImilar Drug switch in juvenile idiopathic arthritis 154
Early predictors of juvenile sacroiliitis in enthesitis-related arthritis. 154
CD38high/HLA-DR+ CD8+ T cells as potential biomarker of hemophagocytic lymphohistiocytosis secondary to visceral Leishmania infection 152
Erratum to: Successful treatment with adalimumab for severe multifocal choroiditis and panuveitis in presumed (early-onset) ocular sarcoidosis 151
Successful treatment of adalimumab in a child with Vogt-Koyanagi-Harada: which is the best available systemic treatment? 151
 A Rare Case of Neonatal Antiphospholipid Syndrome 151
Cervical arthritis as early manifestation of enthesitis-related arthritis complicated by uveitis 150
Convergence and divergence in Kawasaki disease and multisystem inflammatory syndrome in children: results from the COVASAKI survey 147
Development and retrospective validation of the juvenile spondyloarthritis disease activity index. 145
Macrophage activation syndrome/Hemophagocytic Lymphohistiocytosis and Kawasaki disease. 145
Diagnostic challenge of synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) syndrome in pediatric age: A monocentric case series 144
Utility of magnetic resonance imaging when following up sacroiliitis in enthesitis-related arthritis. 142
Elbow monoarthritis: an atypical onset of juvenile idiopathic arthritis. 141
 Possible Correlation Between Congenital Heart Block and Autoimmune Hearing Loss 140
Final height in females and males with precocious puberty after GnRHa treatment 140
Treatment strategies for childhood noninfectious chronic uveitis: an update. 139
Circulating levels of vaspin and omentin, two novel adipokines, in juvenile idiopathic arthritis 132
Oral clonidine provocative test in the diagnosis of growth hormone deficiency (GHD) in childhood: should we make the timing uniform? 131
BONE STATUS OF CHILDREN BORN FROM MOTHERS WITH AUTOIMMUNE DISEASES TREATED DURING PREGNANCY WITH LOW MOLECULAR WEIGHT HEPARIN AND/OR PREDNISONE 131
Biological drugs in paediatric COVID-19 infection: what patients, which drug, how much and how long 131
Cogan Syndrome: a rare but severe vasculitis in pediatric age 130
Idiopathic Inflammatory Myopathies: an Update on Classification and Treatment with Special Focus on Juvenile Forms 129
Growth and body mass index in a cohort of patients with juvenile idiopathic arthritis: effects of second line treatments 129
Superior efficacy of Adalimumab in treating childhood refractory chronic uveitis when used as first biologic modifier drug: Adalimumab as starting anti-TNF-α therapy in childhood chronic uveitis. 126
Cutaneous polyarteritis nodosa and common variable immunodeficiency: a previously unreported association. 125
Kawasaki disease 2013: Clinical cases and new issues 119
Pathogenesis of juvenile idiopathic arthritis: A review of the possible role of different synovial fluid T lymphocyte subsets 119
Anti-Drug Antibodies Are Associated with Diminished Drug Levels and Treatment Failure 116
Distal limb pain as presenting feature of Fabry disease. 115
What do cytokine profiles tell us about subsets of juvenile idiopathic arthritis? 112
Pathogenesis of Juvenile Idiopathic Arthritis: A Review of the Possible Role of Different Synovial Fluid T Lymphocyte Subsets 108
Ineffectiveness of tumor necrosis factor-alpha inhibition in association with bisphosphonates for the treatment of cherubism. 107
Learning-Based Models for Predicting IVIG Resistance and Coronary Artery Lesions in Kawasaki Disease: A Review of Technical Aspects and Study Features 99
Sodium thiosulfate for the treatment of calcinosis secondary to juvenile dermatomyositis. 95
Increased percentages of tumor necrosisfactor-alpha+/interferon-gamma+ lymphocytes and calprotectin+/tumor necrosisfactor-alpha+ monocytes in patients with acute Kawasaki disease 94
Resistance to intravenous immunoglobulin (IVIG) in Kawasaki disease: no influence of different IVIG lot utilisation. 83
Usefulness of autoantibodies against inner ear antigens for the diagnosis 83
Increased percentages of tumor necrosis factor-alpha+/interferon-gamma+ T [corrected] lymphocytes and calprotectin+/tumor necrosis factor-alpha+ monocytes in patients with acute Kawasaki disease. 82
Behçet syndrome in children and adults: discovering similarities and differences by a comparative study 73
null 72
Baricitinib for juvenile idiopathic arthritis: A monocentric case series 18
Behçet syndrome in children and adults: discovering similarities and differences by a comparative study 14
Calcinosis Cutis and Delayed‐Onset Myositis in a Case of Suspected Localized Scleroderma: A Diagnostic and Therapeutic Challenge 13
Totale 11.144
Salva come PNG Salva come JPEG
Categoria #
all - tutte 33.001
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.001
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022514 0 79 69 34 8 12 15 45 17 17 68 150
2022/20231.238 111 276 58 83 72 214 167 59 127 11 31 29
2023/2024456 14 44 71 18 36 109 24 82 12 18 21 7
2024/20253.074 121 308 167 455 950 408 29 204 129 60 123 120
2025/20263.541 361 532 314 295 385 155 392 157 192 185 112 461
2026/2027236 119 117 0 0 0 0 0 0 0 0 0 0
Totale 11.144